Health
New study provides comparative analysis of twelve COVID-19 vaccines – News-Medical.net
A new study by Novateur Ventures provides a comparative analysis of twelve COVID-19 Vaccines that had initiated or announced the Phase III clinical trial stage…
A new study by Novateur Ventures provides a comparative analysis of twelve COVID-19 Vaccines that had initiated or announced the Phase III clinical trial stage by early November 2020. The study highlights the early successes, as well as the hurdles and barriers yet to be overcome for ending the global COVID-19 pandemic.
- messenger RNA – Moderna and Pfizer/BioNtech
- Viral Vector-based (non-replicating) Vaccines – Astra Zeneca/University of Oxford, CanSino Biologics, Gamaleya Research Institute, Johnson…
-
General17 hours agoTributes flow after Australian Paralympic bronze medallist Nicholas Hum dies aged 32
-
General12 hours agoReuven Morrison was killed in the Bondi Beach shooting one year after warning about antisemitism
-
General13 hours agoNT’s top year 12 achievers celebrated, with some looking to pursue teaching careers
-
Noosa News21 hours agoThree taken to hospital, crime scene declared after unit fire in Spring Hill